Medical Xpress June 7, 2023
By University of Illinois at Chicago

Results of clinical trials are only as good as the data upon which they rest. This is especially true in terms of diversity—if most people in a trial are from a certain race or socioeconomic group, then the results may not be broadly applicable.

This form of potential is not a novel concept. But a group of researchers at the University of Illinois Chicago and colleagues has identified a potential hidden source of bias: .

In a recent Contemporary Clinical Trials commentary, the researchers explain how embedded pragmatic clinical trials, or ePCTs, which test the effectiveness of medical interventions in real-world settings, potentially leave out people who are from underrepresented and underserved groups. And even when participants...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, EMR / EHR, Health IT, Patient / Consumer, Provider, Technology, Trends
Increasing EMR System Satisfaction Through Personalisation
The Future of Healthcare: Interoperability and the Patient Experience
Providence, Microsoft apply generative AI to cancer care
How Cleveland Clinic uses Epic to prevent workplace violence
VA plans to resume Oracle EHR rollout by end of FY 2025, secretary says

Share This Article